Skip to main content

Advertisement

SpringerLink
Log in

Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’

  • Letter to the editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M, Pagano F, D’Elios MM, de Bernard M (2011) HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. doi:10.1007/s00262-011-1087-2

  2. Alexandroff AB, Nicholson S, Patel PM, Jackson AM (2010) Recent advances in BCG immunotherapy in malignancy. Immunotherapy 2:551–560

    Article  PubMed  CAS  Google Scholar 

  3. Alexandroff AB, Jackson AM, O’Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694

    Article  PubMed  CAS  Google Scholar 

  4. Jackson AM, James K (1994) Understanding the most successful immunotherapy for cancer. Immunologist 2:208–215

    Google Scholar 

  5. Luo Y, Henning J, O’Donnell MA (2011) Th1 cytokine secreting recombinant mycobacterium bovis Bacillus Calmette-Guerin and prospective use in immunotherapy of bladder cancer. Clin Dev Immunol. doi:10.1155/2011/728930

  6. Rosevear HM, Lightfoot AJ, Birusingh KK, Maymí JL, Nepple KG, O’Donnell MA, National BCG/interferon investigator group (2011) Factors affecting response to bacillus clamette-gurein plus interferon for urothelial carcinoma in situ. J Urol 186:817–823

    Article  PubMed  CAS  Google Scholar 

  7. de Bernard M, D’Elios MM (2010) The immune modulating activity of Helicobacter pylori HP-NAP: friend or foe? Toxicon 15:1186–1192

    Article  Google Scholar 

  8. Gavalas E, Kountouras J, Deretzi G, Boziki M, Zavos C, Venizelos I (2007) Letter to Editor: Helicobacter pylori and multiple sclerosis. J Neuroimmunol 188:187–189

    Google Scholar 

  9. Li W, Minohara M, Piao H, Matsishita T, Masaki K, Matsuoka T, Isobe N, Su JJ, Ohyagi Y, Kira J (2009) Association of anti-Helicobacter pylori neutrophil-activation protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple scleroisis and neuromyelitis optica. Mult Scler 15:1411–1421

    Article  PubMed  CAS  Google Scholar 

  10. Kountouras J et al (2010) Letter to Editor: Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler 16:376–377

    Google Scholar 

  11. Yool AJ (2007) Aquaporins: multiple roles in the central nervous system. Neuroscientist 13:470–485

    Article  PubMed  CAS  Google Scholar 

  12. Venero JL, Vizuete ML, Machado A, Cano J (2001) Aquaporins in the central nervous system. Prog Neurobiol 63:321–336

    Article  PubMed  CAS  Google Scholar 

  13. Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, Kira J (2007) Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 184:227–231

    Article  PubMed  CAS  Google Scholar 

  14. Wender M (2003) Prevalence of Helicobacter pylori infection among patients with multiple sclerosis. Neurol Neurochir Pol 37:45–48

    PubMed  Google Scholar 

  15. Radic M, Kaliterna DM, Rosic J (2011) Heliocbacter pylori infection and systemic sclerosis—is there a link? Joint Bone Spine 78:337–340

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Academic Unit of Clinical Oncology, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK

    Andrew M. Jackson & Hester A. Franks

Authors
  1. Andrew M. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hester A. Franks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew M. Jackson.

Additional information

This letter to the editors is a response to a letter to the editors by Kountouras J et al. also published in Cancer Immunology, Immunotherapy. The letter from Kountouras J et al. refers to the following publication: Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M, Pagano F, D’Elios MM, de Bernard M (2011) HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. doi:10.1007/s00262-011-1087-2.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, A.M., Franks, H.A. Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’. Cancer Immunol Immunother 61, 449–451 (2012). https://doi.org/10.1007/s00262-011-1144-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-011-1144-x

Keywords

Search

Navigation